The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Epstein-Barr virus: Biology and clinical disease
Open accessAbstract
SUMMARY Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of different human malignancies as well as autoimmune disorders. The expression of EBV viral proteins and non-coding RNAs contribute to EBV-mediated disease pathologies. The virus establishes life-long latency in the human host and is adept at evading host innate and adaptive immune responses. In this review, we discuss the lifecycle of EBV, the various functions of EBV encoded proteins and RNAs, the ability of the virus to activate and evade immune responses, as well as the neoplastic and autoimmune diseases that are associated with EBV infection in the human population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049
Kim, S. T., Cristescu, R., Bass, A. J., Kim, K.-M., Odegaard, J. I., Kim, K., Liu, X. Q., Sher, X., Jung, H., Lee, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0101-z · Cited by 1,654
Functional delivery of viral miRNAs via exosomes
Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M. A. J., Hopmans, E. S., Lindenberg, J. L., de Gruijl, T. D., Würdinger, T., & Middeldorp, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914843107 · Cited by 1,641
Cohen, J. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430707 · Cited by 1,636
Identification of Virus-Encoded MicroRNAs
Pfeffer, S., Zavolan, M., Grässer, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D., Sander, C., et al. (2004) · Science · doi:10.1126/science.1096781 · Cited by 1,621
RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway
Chiu, Y.-H., MacMillan, J. B., & Chen, Z. J. (2009) · Cell · doi:10.1016/j.cell.2009.06.015 · Cited by 1,174
Toll‐like Receptor and RIG‐1‐like Receptor Signaling
Kawai, T., & Akira, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.020 · Cited by 986
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
Fingeroth, J. D., Weis, J. J., Tedder, T. F., Strominger, J. L., Biro, P. A., & Fearon, D. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4510 · Cited by 939
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation
Raab-Traub, N., & Flynn, K. (1986) · Cell · doi:10.1016/0092-8674(86)90803-2 · Cited by 912
Self-citationClonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Lanz, T. V., Brewer, R. C., Ho, P. P., Moon, J.-S., Jude, K. M., Fernandez, D., Fernandes, R. A., Gomez, A. M., Nadj, G.-S., Bartley, C. M., et al. (2022) · Nature · doi:10.1038/s41586-022-04432-7 · Cited by 908
Ablasser, A., Bauernfeind, F., Hartmann, G., Latz, E., Fitzgerald, K. A., & Hornung, V. (2009) · Nature Immunology · doi:10.1038/ni.1779 · Cited by 893
Detection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's Disease
Weiss, L. M., Movahed, L. A., Warnke, R. A., & Sklar, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200806 · Cited by 886
Heslop, H. E., Slobod, K. S., Pule, M. A., Hale, G. A., Rousseau, A., Smith, C. A., Bollard, C. M., Liu, H., Wu, M.-F., Rochester, R. J., et al. (2010) · Blood · doi:10.1182/blood-2009-08-239186 · Cited by 780
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
Serafini, B., Rosicarelli, B., Franciotta, D., Magliozzi, R., Reynolds, R., Cinque, P., Andreoni, L., Trivedi, P., Salvetti, M., Faggioni, A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071030 · Cited by 766
Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., & Pagano, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405103101905 · Cited by 723
Self-citationThe Immunology of Epstein-Barr Virus–Induced Disease
Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B., & Hislop, A. D. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112326 · Cited by 602
Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed
Cai, X., Schäfer, A., Lu, S., Bilello, J. P., Desrosiers, R. C., Edwards, R., Raab-Traub, N., & Cullen, B. R. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020023 · Cited by 559
Self-citationHuman tumor virus utilizes exosomes for intercellular communication
Meckes, D. G., Shair, K. H. Y., Marquitz, A. R., Kung, C.-P., Edwards, R. H., & Raab-Traub, N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014194107 · Cited by 541
Self-citationLaichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
Tanner, J., Weis, J., Fearon, D., Whang, Y., & Kieff, E. (1987) · Cell · doi:10.1016/0092-8674(87)90216-9 · Cited by 505
Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
Borza, C. M., & Hutt-Fletcher, L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-594 · Cited by 484
AID Is Required for c-myc/IgH Chromosome Translocations In Vivo
Ramiro, A. R., Jankovic, M., Eisenreich, T., Difilippantonio, S., Chen-Kiang, S., Muramatsu, M., Honjo, T., Nussenzweig, A., & Nussenzweig, M. C. (2004) · Cell · doi:10.1016/j.cell.2004.08.006 · Cited by 465
The cGAS-STING Defense Pathway and Its Counteraction by Viruses
Ma, Z., & Damania, B. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.010 · Cited by 445
Self-citationKlibi, J., Niki, T., Riedel, A., Pioche-Durieu, C., Souquere, S., Rubinstein, E., Le Moulec, S., Guigay, J., Hirashima, M., Guemira, F., et al. (2009) · Blood · doi:10.1182/blood-2008-02-142596 · Cited by 436
Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis
Hjalgrim, H., Askling, J., Rostgaard, K., Hamilton-Dutoit, S., Frisch, M., Zhang, J.-S., Madsen, M., Rosdahl, N., Konradsen, H. B., Storm, H. H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023141 · Cited by 433
Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
Haneklaus, M., Gerlic, M., Kurowska-Stolarska, M., Rainey, A.-A., Pich, D., McInnes, I. B., Hammerschmidt, W., O’Neill, L. A. J., & Masters, S. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200312 · Cited by 411
Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity
Harley, J. B., Chen, X., Pujato, M., Miller, D., Maddox, A., Forney, C., Magnusen, A. F., Lynch, A., Chetal, K., Yukawa, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0102-3 · Cited by 406
Primary infection with the Epstein‐Barr virus and risk of multiple sclerosis
Levin, L. I., Munger, K. L., O'Reilly, E. J., Falk, K. I., & Ascherio, A. (2010) · Annals of Neurology · doi:10.1002/ana.21978 · Cited by 404
Feederle, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.3080 · Cited by 387
Hammerschmidt, W., & Sugden, B. (1988) · Cell · doi:10.1016/0092-8674(88)90028-1 · Cited by 381
Deacon, E. M., Pallesen, G., Niedobitek, G., Crocker, J., Brooks, L., Rickinson, A. B., & Young, L. S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.339 · Cited by 356
Balfour, H. H., Odumade, O. A., Schmeling, D. O., Mullan, B. D., Ed, J. A., Knight, J. A., Vezina, H. E., Thomas, W., & Hogquist, K. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis646 · Cited by 337
Lünemann, J. D., Jelčić, I., Roberts, S., Lutterotti, A., Tackenberg, B., Martin, R., & Münz, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072397 · Cited by 334
EB virus‐encoded RNAs are recognized by RIG‐I and activate signaling to induce type I IFN
Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T., & Takada, K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601314 · Cited by 311
Self-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1
Yin, Y., Manoury, B., & Fåhraeus, R. (2003) · Science · doi:10.1126/science.1088902 · Cited by 296
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus
Poole, B. D., Scofield, R. H., Harley, J. B., & James, J. A. (2006) · Autoimmunity · doi:10.1080/08916930500484849 · Cited by 286
Regulation of the latent-lytic switch in Epstein–Barr virus
Kenney, S. C., & Mertz, J. E. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.002 · Cited by 281
Self-citationEpstein-Barr virus provides a survival factor to Burkitt's lymphomas
Kennedy, G., Komano, J., & Sugden, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336099100 · Cited by 276
Detection of ebv gene expression in reed‐sternberg cells of Hodgkin's disease
Wu, T., Mann, R. B., Charache, P., Hayward, S. D., Staal, S., Lambe, B. C., & Ambinder, R. F. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460509 · Cited by 275
Viral effects on the content and function of extracellular vesicles
Raab-Traub, N., & Dittmer, D. P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.60 · Cited by 269
Self-citationBalfour, H. H., Sifakis, F., Sliman, J. A., Knight, J. A., Schmeling, D. O., & Thomas, W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit321 · Cited by 266
Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity
Chiang, J. J., Sparrer, K. M. J., van Gent, M., Lässig, C., Huang, T., Osterrieder, N., Hopfner, K.-P., & Gack, M. U. (2018) · Nature Immunology · doi:10.1038/s41590-017-0005-y · Cited by 259
Fries, K. L., Miller, W. E., & Raab-Traub, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8653-8659.1996 · Cited by 255
Self-citationMancao, C., & Hammerschmidt, W. (2007) · Blood · doi:10.1182/blood-2007-05-090142 · Cited by 250
Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry
Zhang, H., Li, Y., Wang, H.-B., Zhang, A., Chen, M.-L., Fang, Z.-X., Dong, X.-D., Li, S.-B., Du, Y., Xiong, D., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0080-8 · Cited by 248
Molecular biology of Hodgkin lymphoma
Weniger, M. A., & Küppers, R. (2021) · Leukemia · doi:10.1038/s41375-021-01204-6 · Cited by 248
TRIM29 promotes DNA virus infections by inhibiting innate immune response
Xing, J., Zhang, A., Zhang, H., Wang, J., Li, X. C., Zeng, M.-S., & Zhang, Z. (2017) · Nature Communications · doi:10.1038/s41467-017-00101-w · Cited by 247
Defective Epstein–Barr virus in chronic active infection and haematological malignancy
Okuno, Y., Murata, T., Sato, Y., Muramatsu, H., Ito, Y., Watanabe, T., Okuno, T., Murakami, N., Yoshida, K., Sawada, A., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0334-0 · Cited by 239
Prockop, S., Doubrovina, E., Suser, S., Heller, G., Barker, J., Dahi, P., Perales, M. A., Papadopoulos, E., Sauter, C., Castro-Malaspina, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci121127 · Cited by 239
Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A., & Kieff, E. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6826-6837.1991 · Cited by 236
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma
Tiacci, E., Ladewig, E., Schiavoni, G., Penson, A., Fortini, E., Pettirossi, V., Wang, Y., Rosseto, A., Venanzi, A., Vlasevska, S., et al. (2018) · Blood · doi:10.1182/blood-2017-11-814913 · Cited by 233
Zalani, S., Holley-Guthrie, E., & Kenney, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9194 · Cited by 227
Self-citationEpstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model
Hong, G. K., Gulley, M. L., Feng, W.-H., Delecluse, H.-J., Holley-Guthrie, E., & Kenney, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13993-14003.2005 · Cited by 225
Self-citationNeuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
Wang, H.-B., Zhang, H., Zhang, J.-P., Li, Y., Zhao, B., Feng, G.-K., Du, Y., Xiong, D., Zhong, Q., Liu, W.-L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7240 · Cited by 215
Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus
Chen, J., Sathiyamoorthy, K., Zhang, X., Schaller, S., Perez White, B. E., Jardetzky, T. S., & Longnecker, R. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0081-7 · Cited by 210
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma
Bräuninger, A., Schmitz, R., Bechtel, D., Renné, C., Hansmann, M., & Küppers, R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21716 · Cited by 202
Epidemiology: clues to the pathogenesis of Burkitt lymphoma
Magrath, I. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09013.x · Cited by 195
The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome
Bhende, P. M., Seaman, W. T., Delecluse, H.-J., & Kenney, S. C. (2004) · Nature Genetics · doi:10.1038/ng1424 · Cited by 192
Self-citationJochum, S., Moosmann, A., Lang, S., Hammerschmidt, W., & Zeidler, R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002704 · Cited by 188
Hochberg, D., Souza, T., Catalina, M., Sullivan, J. L., Luzuriaga, K., & Thorley-Lawson, D. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5194-5204.2004 · Cited by 181
Bu, W., Joyce, M. G., Nguyen, H., Banh, D. V., Aguilar, F., Tariq, Z., Yap, M. L., Tsujimura, Y., Gillespie, R. A., Tsybovsky, Y., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.010 · Cited by 180
Epstein–Barr virus maintains lymphomas via its miRNAs
Vereide, D. T., Seto, E., Chiu, Y.-F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W., & Sugden, B. (2014) · Oncogene · doi:10.1038/onc.2013.71 · Cited by 171
Epstein-Barr virus enters B cells and epithelial cells by different routes
Miller, N., & Hutt-Fletcher, L. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3409-3414.1992 · Cited by 167
Rickinson, A. B., Long, H. M., Palendira, U., Münz, C., & Hislop, A. D. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.01.003 · Cited by 166
Kalla, M., Schmeinck, A., Bergbauer, M., Pich, D., & Hammerschmidt, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911948107 · Cited by 166
Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8 + T cells
Albanese, M., Tagawa, T., Bouvet, M., Maliqi, L., Lutter, D., Hoser, J., Hastreiter, M., Hayes, M., Sugden, B., Martin, L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605884113 · Cited by 164
Epstein-Barr Virus Induces MCP-1 Secretion by Human Monocytes via TLR2
Gaudreault, E., Fiola, S., Olivier, M., & Gosselin, J. (2007) · Journal of Virology · doi:10.1128/jvi.00403-07 · Cited by 163
Strong, M. J., Xu, G., Coco, J., Baribault, C., Vinay, D. S., Lacey, M. R., Strong, A. L., Lehman, T. A., Seddon, M. B., Lin, Z. N., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003341 · Cited by 160
Kataoka, K., Miyoshi, H., Sakata, S., Dobashi, A., Couronné, L., Kogure, Y., Sato, Y., Nishida, K., Gion, Y., Shiraishi, Y., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0380-5 · Cited by 160
Pudney, V. A., Leese, A. M., Rickinson, A. B., & Hislop, A. D. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041542 · Cited by 158
Morrison, J. A., Gulley, M. L., Rajadurai, P., & Raab‐Traub, N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0538 · Cited by 154
Self-citationOk, C. Y., Li, L., Xu-Monette, Z. Y., Visco, C., Tzankov, A., Manyam, G. C., Montes‐Moreno, S., Dybkær, K., Chiu, A., Orazi, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3157 · Cited by 153
Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
Ogembo, J. G., Kannan, L., Ghiran, I. C., Nicholson-Weller, A., Finberg, R. W., Tsokos, G. C., & Fingeroth, J. D. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.023 · Cited by 153
Hodgkin lymphoma: Pathology and biology
Mathas, S., Hartmann, S., & Küppers, R. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.05.007 · Cited by 148
van Gent, M., Braem, S., de Jong, A., Delagic, N., Peeters, J. G. C., Boer, I. G. J., Moynagh, P. N., Kremmer, E., Wiertz, E. J. H. J., Ovaa, H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003960 · Cited by 145
Toll-like receptor signaling controls reactivation of KSHV from latency
Gregory, S. M., West, J. A., Dillon, P., Hilscher, C., Dittmer, D. P., & Damania, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905316106 · Cited by 141
Self-citationConstitutive activation of distinct NF‐κB signals in EBV ‐associated nasopharyngeal carcinoma
Chung, G. T., Lou, W. P.-K., Chow, C., To, K., Choy, K. W., Leung, A. W.-C., Tong, C. Y., Yuen, J. W.-F., Ko, C., Yip, T. T., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4239 · Cited by 140
Epstein–Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6
Luftig, M. A., Prinarakis, E., Yasui, T., Tsichritzis, T., Cahir-McFarland, E. D., Inoue, J., Nakano, H., Mak, T. W., Yeh, W., Li, X., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136756100 · Cited by 138
Epstein–Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity
Cheng, A. Z., Yockteng-Melgar, J., Jarvis, M. C., Malik-Soni, N., Borozan, I., Carpenter, M. A., McCann, J. L., Ebrahimi, D., Shaban, N. M., Marcon, E., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0284-6 · Cited by 138
EBV Tegument Protein BNRF1 Disrupts DAXX-ATRX to Activate Viral Early Gene Transcription
Tsai, K., Thikmyanova, N., Wojcechowskyj, J. A., Delecluse, H., & Lieberman, P. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002376 · Cited by 136
Cancers associated with human gammaherpesviruses
Wen, K. W., Wang, L., Menke, J. R., & Damania, B. (2021) · FEBS Journal · doi:10.1111/febs.16206 · Cited by 136
Self-citationSpriggs, M. K., Armitage, R. J., Comeau, M. R., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5557-5563.1996 · Cited by 135
Messick, T. E., Smith, G. R., Soldan, S. S., McDonnell, M. E., Deakyne, J. S., Malecka, K. A., Tolvinski, L., van den Heuvel, A. P. J., Gu, B.-W., Cassel, J. A., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5612 · Cited by 134
Serafini, B., Rosicarelli, B., Veroni, C., Mazzola, G. A., & Aloisi, F. (2019) · Journal of Virology · doi:10.1128/jvi.00980-19 · Cited by 133
Bruce, J. P., To, K., Lui, V. W. Y., Chung, G. T. Y., Chan, Y., Tsang, C. M., Yip, K. Y.-L., Ma, B. B. Y., Woo, J. K. S., Hui, E. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24348-6 · Cited by 131
MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1
Jung, Y., Choi, H., Kim, H., & Lee, S. K. (2014) · Journal of Virology · doi:10.1128/jvi.00721-14 · Cited by 124
Hatzivassiliou, E., Miller, W. E., Raab‐Traub, N., Kieff, E. D., & Mosialos, G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1116 · Cited by 123
Self-citationEpstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
Lu, Y., Qin, Z., Wang, J., Zheng, X., Lu, J., Zhang, X., Wei, L., Qiu, P., Zheng, Y., Ou, C., et al. (2017) · Journal of Innate Immunity · doi:10.1159/000479749 · Cited by 122
MYC Controls the Epstein-Barr Virus Lytic Switch
Guo, R., Jiang, C., Zhang, Y., Govande, A. A., Trudeau, S. J., Chen, F., Fry, C. J., Puri, R., Wolinsky, E., Schineller, M., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.025 · Cited by 119
EBV Latent Membrane Protein 1 Is a Negative Regulator of TLR9
Fathallah, I., Parroche, P., Gruffat, H., Zannetti, C., Johansson, H., Yue, J., Manet, É., Tommasino, M., Sylla, B. S., & Hasan, U. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903459 · Cited by 118
Epstein-Barr virus and rheumatoid arthritis
Balandraud, N., & Roudier, J. (2017) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.04.011 · Cited by 118
Hong, G. K., Kumar, P., Wang, L., Damania, B., Gulley, M. L., Delecluse, H., Polverini, P. J., & Kenney, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13984-13992.2005 · Cited by 116
Self-citationHatzivassiliou, E., Miller, W. E., Raab‐Traub, N., Kieff, E. D., & Mosialos, G. (1998) · PubMed · Cited by 115
Self-citationInnate immune control of EBV-infected B cells by invariant natural killer T cells
Chung, B. K., Tsai, K., Allan, L. L., Zheng, D. J., Nie, J. C., Biggs, C. M., Hasan, M. R., Kozak, F. K., van den Elzen, P., Priatel, J. J., et al. (2013) · Blood · doi:10.1182/blood-2013-01-480665 · Cited by 114
Gilligan, K. J., Rajadurai, P., Lin, J. C., Busson, P., Abdel‐Hamid, M., Prasad, U., Tursz, T., & Raab‐Traub, N. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.6252-6259.1991 · Cited by 112
Self-citationA Multifactorial Role for P. falciparum Malaria in Endemic Burkitt's Lymphoma Pathogenesis
Torgbor, C., Awuah, P. C., Deitsch, K., Kalantari, P., Duca, K., & Thorley‐Lawson, D. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004170 · Cited by 111
Nawandar, D. M., Wang, A., Makielski, K. R., Lee, D., Ma, S., Barlow, E. A., Reusch, J. A., Jiang, R., Wille, C. K., Greenspan, D., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005195 · Cited by 109
Self-citationGenome-wide siRNA screen for mediators of NF-κB activation
Gewurz, B. E., Towfic, F., Mar, J. C., Shinners, N. P., Takasaki, K., Zhao, B., Cahir-McFarland, E. D., Quackenbush, J., Xavier, R. J., & Kieff, E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120542109 · Cited by 108
Saito, S., Murata, T., Kanda, T., Isomura, H., Narita, Y., Sugimoto, A., Kawashima, D., & Tsurumi, T. (2013) · Journal of Virology · doi:10.1128/jvi.02020-12 · Cited by 105
Njie, R., Bell, A. I., Jia, H., Croom-Carter, D. S. G., Chaganti, S., Hislop, A. D., Whittle, H. C., & Rickinson, A. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/594373 · Cited by 105
Vilmen, G., Glon, D., Siracusano, G., Lussignol, M., Shao, Z., Hernández, E., Perdiz, D., Quignon, F., Mouna, L., Poüs, C., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1758416 · Cited by 101
Mediation of Epstein–Barr virus EBNA‐LP transcriptional coactivation by Sp100
Ling, P. D., Peng, R. S., Nakajima, A., Jiang, Y., Tan, J., Moses, S. C., Yang, W.-H., Zhao, B., Kieff, E. D., Bloch, K. D., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600820 · Cited by 97
Pagano, J. S., Whitehurst, C. B., & Andreï, G. (2018) · Cancers · doi:10.3390/cancers10060197 · Cited by 97
Wei, C.-J., Bu, W., Nguyen, L., Batchelor, J., Kim, J., Pittaluga, S., Fuller, J., Nguyen, H., Chou, T.-H., Cohen, J. I., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abf3685 · Cited by 97
Lymphomas differ in their dependence on Epstein-Barr virus
Vereide, D. T., & Sugden, B. (2010) · Blood · doi:10.1182/blood-2010-05-285791 · Cited by 95
Enzymatic Blockade of the Ubiquitin-Proteasome Pathway
Ernst, R., Claessen, J. H. L., Mueller, B., Sanyal, S., Spooner, E., van der Veen, A. G., Kirak, O., Schlieker, C. D., Weihofen, W. A., & Ploegh, H. L. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000605 · Cited by 95
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
Bristol, J. A., Djavadian, R., Albright, E. R., Coleman, C. B., Ohashi, M., Hayes, M., Romero-Masters, J. C., Barlow, E. A., Farrell, P. J., Rochford, R. A., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007179 · Cited by 95
Self-citationEBV Lytic-Phase Protein BGLF5 Contributes to TLR9 Downregulation during Productive Infection
van Gent, M., Griffin, B. D., Berkhoff, E. G. M., van Leeuwen, D., Boer, I. G. J., Buisson, M., Hartgers, F. C., Burmeister, W. P., Wiertz, E. J. H. J., & Ressing, M. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903120 · Cited by 94
Quinn, L. L., Williams, L. R., White, C., Forrest, C., Zuo, J., & Rowe, M. (2015) · Journal of Virology · doi:10.1128/jvi.02183-15 · Cited by 94
NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
Chijioke, O., Landtwing, V., & Münz, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00323 · Cited by 87
Malpica, L., Marques-Piubelli, M. L., Beltrán, B., Chávez, J. C., Miranda, R. N., & Castillo, J. J. (2022) · American Journal of Hematology · doi:10.1002/ajh.26579 · Cited by 87
Unique Signaling Properties of CTAR1 in LMP1-Mediated Transformation
Mainou, B. A., Everly, D. N., & Raab‐Traub, N. (2007) · Journal of Virology · doi:10.1128/jvi.01001-07 · Cited by 86
Self-citationMiller, W. E., Cheshire, J. L., & Raab‐Traub, N. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2835 · Cited by 84
Self-citationKraus, R. J., Yu, X., Cordes, B.-L. A., Sathiamoorthi, S., Iempridee, T., Nawandar, D. M., Ma, S., Romero-Masters, J. C., McChesney, K., Lin, Z. N., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006404 · Cited by 84
Self-citationEpithelial cell infection by Epstein–Barr virus
Chen, J., & Longnecker, R. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz023 · Cited by 83
Regulation of Epstein—Barr virus latency by latent membrane protein 2
Longnecker, R., & Miller, C. L. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)81504-6 · Cited by 82
Liu, X., Sadaoka, T., Krogmann, T. A., & Cohen, J. I. (2020) · Journal of Virology · doi:10.1128/jvi.00258-20 · Cited by 82
Mahot, S., Sergeant, A., Drouet, E., & Gruffat, H. (2003) · Journal of General Virology · doi:10.1099/vir.0.18845-0 · Cited by 81
Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain
Flemington, E. K., Borras, A. M., Lytle, J. P., & Speck, S. H. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.922-929.1992 · Cited by 79
Kalchschmidt, J., Bashford-Rogers, R. J. M., Paschos, K., Gillman, A. C. T., Styles, C. T., Kellam, P., & Allday, M. J. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160120 · Cited by 79
Djaoud, Z., Guethlein, L. A., Horowitz, A., Azzi, T., Nemat‐Gorgani, N., Olive, D., Nadal, D., Norman, P. J., Münz, C., & Parham, P. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161017 · Cited by 79
Price, A. M., Dai, J., Bazot, Q., Patel, L., Nikitin, P. A., Djavadian, R., Winter, P. S., Salinas, C. A., Barry, A. P., Wood, K. C., et al. (2017) · eLife · doi:10.7554/elife.22509 · Cited by 76
Styles, C. T., Bazot, Q., Parker, G. A., White, R. E., Paschos, K., & Allday, M. J. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2001992 · Cited by 73
Marquitz, A. R., Mathur, A., Edwards, R. H., & Raab‐Traub, N. (2015) · Journal of Virology · doi:10.1128/jvi.01492-15 · Cited by 72
Self-citationCD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells
Smith, N. A., Coleman, C. B., Gewurz, B. E., & Rochford, R. A. (2020) · Journal of Virology · doi:10.1128/jvi.00428-20 · Cited by 72
Li, X., Burton, E. M., & Bhaduri‐McIntosh, S. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006249 · Cited by 71
The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis
Stanland, L. J., & Luftig, M. A. (2020) · Viruses · doi:10.3390/v12111222 · Cited by 71
Bentz, G. L., Whitehurst, C. B., & Pagano, J. S. (2011) · Journal of Virology · doi:10.1128/jvi.05035-11 · Cited by 69
Jones, R. J., Seaman, W. T., Feng, W., Barlow, E. A., Dickerson, S., Delecluse, H., & Kenney, S. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22839 · Cited by 65
Self-citationEBV-Induced Human CD8+ NKT Cells Suppress Tumorigenesis by EBV-Associated Malignancies
He, Y., Ruijing, X., Li, L., Ji, X., Rui, Z., Wang, Y., Lijun, Z., Chunxian, D., Xinti, T., Wei, X., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0828 · Cited by 63
A promiscuous inflammasome sparks replication of a common tumor virus
Burton, E. M., Goldbach‐Mansky, R. T., & Bhaduri‐McIntosh, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919133117 · Cited by 62
Early‐life exposures to infectious agents and later cancer development
Vedham, V., Verma, M., & Mahabir, S. (2015) · Cancer Medicine · doi:10.1002/cam4.538 · Cited by 61
DNA methylation enzymes and PRC1 restrict B-cell Epstein–Barr virus oncoprotein expression
Guo, R., Zhang, Y., Teng, M., Jiang, C., Schineller, M., Zhao, B., Doench, J. G., O’Reilly, R. J., Cesarman, E., Giulino-Roth, L. G., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0724-y · Cited by 61
Djavadian, R., Chiu, Y., & Johannsen, E. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005718 · Cited by 60
Chiu, Y., Sugden, A. U., & Sugden, B. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.11.009 · Cited by 58
Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients
Callan, M. F. C. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000126149.96627.82 · Cited by 58
Smith, D. W., Chakravorty, A., Hayes, M., Hammerschmidt, W., & Sugden, B. (2021) · mBio · doi:10.1128/mbio.02243-21 · Cited by 58
Simone, O., Bejarano, M. T., Pierce, S. K., Antonaci, S., Wahlgren, M., Troye‐Blomberg, M., & Donati, D. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2011.05.005 · Cited by 54
Gupta, S., Ylä‐Anttila, P., Sandalova, T., Sun, R., Achour, A., & Masucci, M. G. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008146 · Cited by 53
Duan, Y., Li, Z., Cheng, S., Chen, Y., Zhang, L., Jiang, H., Liao, Q., Yang, L., Gong, Z., & Sun, L. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.037 · Cited by 52
Li, Z., Tsai, M., Shumilov, A., Baccianti, F., Tsao, S. W., Poirey, R., & Delecluse, H. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0546-y · Cited by 52
Tzellos, S., Correia, P. B., Karstegl, C. E., Cancian, L., Cano-Flanagan, J., McClellan, M. J., West, M. J., & Farrell, P. J. (2014) · Journal of Virology · doi:10.1128/jvi.01000-14 · Cited by 50
Lunn, R. M., Jahnke, G. D., & Rabkin, C. S. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0266 · Cited by 46
Pisano, G., Roy, A., Ansari, M. A., Kumar, B., Leela, C., & Chandran, B. (2017) · Virology Journal · doi:10.1186/s12985-017-0891-5 · Cited by 46
Deng, Z., Chen, C., Chamberlin, M., Lu, F. Y., Blobel, G. A., Speicher, D. W., Cirillo, L. A., Zaret, K. S., & Lieberman, P. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2633-2644.2003 · Cited by 44
Rostgaard, K., Wohlfahrt, J., & Hjalgrim, H. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu204 · Cited by 43
5-hydroxymethylation of the EBV genome regulates the latent to lytic switch
Wille, C. K., Nawandar, D. M., Henning, A. N., Ma, S., Oetting, K. M., Lee, D. M., Lambert, P. F., Johannsen, E., & Kenney, S. C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513432112 · Cited by 43
Self-citationAn essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation
Pei, Y., Banerjee, S., Jha, H. C., Sun, Z., & Robertson, E. S. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006500 · Cited by 42
Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo
Anderson, L. J., & Longnecker, R. (2008) · Blood · doi:10.1182/blood-2008-06-160937 · Cited by 40
Chesnokova, L. S., Ahuja, M. K., & Hutt‐Fletcher, L. M. (2014) · Journal of Virology · doi:10.1128/jvi.01597-14 · Cited by 40
Activation and Evasion of Innate Immunity by Gammaherpesviruses
Lange, P. T., White, M. C., & Damania, B. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167214 · Cited by 32
Self-citationEpstein-Barr Virus Latent Membrane Protein 2 Induces Autophagy To Promote Abnormal Acinus Formation
Fotheringham, J., & Raab‐Traub, N. (2015) · Journal of Virology · doi:10.1128/jvi.03371-14 · Cited by 31
Self-citationLi, Z., Baccianti, F., Delécluse, S., Tsai, M., Shumilov, A., Cheng, X., Ma, S., Hoffmann, I., Poirey, R., & Delecluse, H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115508118 · Cited by 31
Sciver, N. V., Ohashi, M., Pauly, N. P., Bristol, J. A., Nelson, S. E., Johannsen, E., & Kenney, S. C. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009783 · Cited by 29
Self-citationGammaherpesvirus RNAs Come Full Circle
Ungerleider, N., Tibbetts, S. A., Renne, R., & Flemington, E. K. (2019) · mBio · doi:10.1128/mbio.00071-19 · Cited by 25
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells
Bristol, J. A., Brand, J., Ohashi, M., Eichelberg, M. R., Casco, A., Nelson, S. E., Hayes, M., Romero-Masters, J. C., Baiu, D. C., Gumperz, J. E., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010453 · Cited by 22
Self-citationKSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation
Bentz, G. L., Bheda-Malge, A., Wang, L., Shackelford, J., Damania, B., & Pagano, J. S. (2013) · Virology · doi:10.1016/j.virol.2013.10.018 · Cited by 20
Self-citationVerma, D., Church, T. M., & Swaminathan, S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000625117 · Cited by 16
ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells
Sciver, N. V., Ohashi, M., Nawandar, D. M., Pauly, N. P., Lee, D., Makielski, K. R., Bristol, J. A., Tsao, S. W., Lambert, P. F., Johannsen, E., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010045 · Cited by 16
Self-citation
Cited by
Mechanisms of long COVID and the path toward therapeutics
Peluso, M. J., & Deeks, S. G. (2024) · Cell · doi:10.1016/j.cell.2024.07.054 · Cited by 341
Chronic viral coinfections differentially affect the likelihood of developing long COVID
Peluso, M. J., Deveau, T.-M., Munter, S. E., Ryder, D., Buck, A., Beck-Engeser, G., Chan, F., Lu, S., Goldberg, S. A., Hoh, R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163669 · Cited by 254
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
Bjornevik, K., Münz, C., Cohen, J. I., & Ascherio, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00775-5 · Cited by 246
Metadata
- Authors
- Damania, B., Kenney, S. C., & Raab-Traub, N.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 185
- Issue
- 20
- Pages
- 3652-3670
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4295921243
- Cited by
- 612
- References
- 160
- FWCI
- 37.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.